Background: A study to investigate transmission of classical scrapie via goat milk was carried out in sheep: firstly, lambs were challenged orally with goat scrapie brain homogenate to confirm transmission of scrapie from goats to sheep. In the second study phase, milk from scrapie-infected goats was fed to lambs. Lambs were selected according to their prion protein gene (PRNP) genotype, which was either VRQ/VRQ or ARQ/ARQ, with or without additional polymorphisms at codon 141 (FF 141 , LF 141 or LL 141 ) of the ovine PRNP. This report describes the clinical, pathological and molecular phenotype of goat scrapie in those sheep that progressed to clinical end-stage. Results: Ten sheep (six VRQ/VRQ and four ARQ/ARQ, of which three FF 141 and one LL 141 ) challenged with one of two scrapie brain homogenates, and six pairs of sheep (ARQ, of which five LL 141 and seven LF 141 ) fed milk from six different goats, developed clinical disease, which was characterised by a pruritic (all VRQ/VRQ and LL 141 sheep) or a non-pruritic form (all LF 141 and FF 141 sheep). Immunohistochemical (IHC) examination revealed that the pattern of intra-and extracellular accumulation of disease-associated prion protein in the brain was also dependent on PRNP polymorphisms at codon 141, which was similar in VRQ and LL 141 sheep but different from LF 141 and FF 141 sheep. The influence of codon 141 was also seen in discriminatory Western blot (WB), with LF 141 and FF 141 sheep showing a bovine spongiform encephalopathy-like profile (diminished reactivity with P4 antibody) on brain tissue. However, discriminatory WB in lymphoid tissues, and IHC pattern and profile both in lymphoid and brain tissue was consistent with classical scrapie in all sheep. Conclusions: This study provided further evidence that the clinical presentation and the pathological and molecular phenotypes of scrapie in sheep are influenced by PRNP polymorphisms, particularly at codon 141. Differences in the truncation of disease-associated prion protein between LL 141 sheep and those carrying the F 141 allele may be responsible for these observations.
Background
Classical scrapie is a transmissible spongiform encephalopathy (TSE) of sheep and goats that can be transmitted vertically from dam to offspring and horizontally between animals. Horizontal transmission was demonstrated not only between conspecifics but also from sheep to goats under natural conditions [1, 2] , whereas natural transmission from goats to sheep has not been reported. One study described the successful transmission of goat scrapie to sheep by intracerebral inoculation of pooled goat brains [3] but this was prior to the development of more sensitive diagnostic methods and before the effect of prion protein gene (PRNP) genotype on disease susceptibility was known.
Three codons are considered important regarding scrapie susceptibility in sheep: codon 136, encoding alanine (A) or valine (V), codon 154, encoding arginine (R) or histidine (H) and codon 171, encoding glutamine (Q) or arginine (R). In Cheviot sheep, the most susceptible genotype is VV at codon 136, RR at codon 154 and QQ at codon 171 (VV 136 RR 154 QQ 171 ) whereas AA 136 RR 154 RR 171 sheep are considered highly resistant [4] . There are other PRNP polymorphisms, such as phenylalanine (F) instead of leucine (L) at codon 141, which have been associated with atypical scrapie cases [5] , and increased survival times were reported in AA 136 Cheviot sheep with an F 141 allele, which had been experimentally inoculated with classical scrapie [6] . PRNP polymorphisms also affect classical scrapie susceptibility in goats. For example, lysine (K) instead of glutamine (Q) at codon 222 is associated with increased resistance, and methionine (M) instead of isoleucine (I) at codon 142 is linked to an increased survival time [7] .
A more recent study demonstrated transmission of classical scrapie from a goat (II 142 ) to two of four VV 136 RR 154 QQ 171 sheep by oral inoculation with placenta [8] but there was very limited information on the disease phenotype.
The study reported here aimed to provide more detailed information about the clinical, pathological and molecular phenotype of caprine classical scrapie in sheep, in particular with respect to PRNP polymorphisms at codon 141 that were detected in these sheep. The disease was produced as part of an experiment to assess the infectivity of goat milk following a pilot study to determine susceptibility of sheep to goat scrapie, the results of which were presented separately [9] .
Methods

Animal studies
For the pilot study to determine susceptibility of sheep to goat scrapie, brain homogenates were prepared from two naturally infected Anglo-Nubian goats [10] according to established methods [11] : G1460 with II 142 and G1451 with IM 142 PRNP genotypes. All goats were from a herd that was culled to eradicate scrapie in accordance with Regulation (EC) No 999/2001 and its amendments laying down rules for the prevention, control and eradication of certain transmissible spongiform encephalopathies. More details on these goats are provided elsewhere [12, 13] .
Brain recipients were 10 Cheviot lambs with PRNP genotypes VV 136 RR 154 QQ 171 (n = 6, subsequently called VV) and AA 136 RR 154 QQ 171 (n = 4, subsequently called AA) born from six ewes from our research flock that was established in England to provide classical scrapiefree sheep for research purposes [14] . PRNP genotyping was performed as described previously [15] and included polymorphisms at codon 141, which have shown to influence disease in experimentally infected AA sheep [6] The lambs were orally challenged within 24 h of birth with 5 g (as 10% w/v solution in physiological saline) of one of the two goat brain homogenates. Lambs were raised by their dams until weaning at approximately 10 weeks of age in three pens, two of which contained lambs challenged with either G1460 or G1451 brain and one housed a mixture of lambs challenged with G1460 or G1451 brain (Table 1) . Lambs from the different pens were mixed from 35 months of age when the number of animals started to decline.
For the milk transmission study, recipients were six pairs of AA lambs with either LL 141 or LF 141 PRNP polymorphisms from the same classical scrapie-free flock because the pilot study implied that AA sheep were more suitable as recipients than VV sheep. As mentioned above, uniform genotypes at codon 141 could not be pre-selected in the recipient sheep although this time dams and sire were chosen to produce either LL 141 or LF 141 lambs because infection in the pilot study was first demonstrated in AA sheep with an L 141 allele [9] . The lambs were fed milk from six different scrapie-infected goats (volume 38-87 l per lamb), which were all from the same herd and included the two goats that also provided brains for the pilot study. Once all the goat milk was consumed, lambs were fed milk replacer (Lamlac, Volac International Ltd., Orwell, UK). Pairs of milk recipients were kept separate until scrapie infection was confirmed by rectal biopsy (see below), at which time they were mixed. All sheep were fed straw and concentrates after weaning at approximately 10 weeks of age.
A graphic representation of the study design is provided as Additional file 1: study design.
Monitoring scrapie infection status
Scrapie infection status was determined by the immunohistochemical examination of biopsies of recto-anal mucosa-associated lymphoid tissue (RAMALT) [16] from 6 months (pilot study) and 9 months (milk transmission study) of age; rectal biopsies were repeated only in sheep with previously negative results.
Sheep were monitored twice daily by farm staff and were systematically examined for neurological signs first at 20 months of age, then at 31 months and then usually monthly or more frequently depending on clinical status, using a short examination protocol for detection of scrapie [17] . A full neurological examination [11] was carried out prior to culling, and an electrocardiogram was recorded as described previously [18] in those sheep where cardiac arrhythmia was suspected during the physical examination. To document progressive pruritic behaviour, a scratch test score was calculated retrospectively. This was the number of consecutive positive responses (unequivocal stereotypical behaviour [19] until culling divided by the total number of clinical assessments ranging from 0 (no response prior to cull) to 1 (response at each assessment until cull). Inconclusive responses [19] counted towards positive reactions if they occurred prior to a positive response because it was interpreted as early sign of pruritus consistent with the progressive nature of scrapie. Thus, an inconclusive response followed by no scratch response on the subsequent examination or a positive scratch test that disappeared prior to culling did not count as consecutive positive response until culling because clinical signs were less likely to be associated with a progressive disease if they disappeared.
Assessments were made blind without knowledge of the genotype or inoculum although the scrapie status was known once animals were mixed. Sheep were euthanased with intravenous injection of secobarbital and cinchocaine (Somulose, Dechra, Shrewsbury, UK) at clinical end-point, which was reached when animals displayed progressive abnormalities in sensation (positive scratch test with or without alopecia, absent menace response) and movement (ataxia, limb weakness, tremor).
Post-mortem investigation
The brain and a range of lymphoid tissues were taken and processed for immunohistochemistry (IHC) and Western immunoblot (WB) examination. [20, 21] . The discriminatory IHC was applied to nine AA sheep, three each with the different polymorphisms at codon 141, which had similar scrapie-associated prion protein (PrP sc ) profiles and total amount of PrP sc (see below). A naturally infected classical scrapie sheep, a sheep orally challenged with BSE brain homogenate and a sheep intracerebrally inoculated with CH1641 brain homogenate were used as controls; all three controls were AALL 141 . The robustness of the discriminatory IHC has been previously demonstrated [20] .
Lesion profiling was carried out as described previously [6] : tissue sections of the brain at seven levels were immunolabelled with antibody R145 for simplified scoring of PrP sc on a scale from 0 (none) to 3 (striking) in steps of 0.5 and including 0.2 for trace immunolabelling. Five different PrP sc patterns were distinguished: i) intraneuronal, ii) intraglial (intramicroglial and intrastrocytic types combined), iii) extracellular glia-associated (subpial, subependymal, perivascular, stellate and perivacuolar types combined), iv) grey matter neuropilassociated (diffuse particulate, coalescing, perineuronal and linear types combined), and v) other types (ependymal, vascular plaque and non-vascular plaque types combined). The average value for each PrP sc pattern from the seven areas examined was used to create an individual PrP sc profile and, for grouping by genotype, the profiles constituted the mean of the individual sheep profiles within each genotype group.
WB examination for detection of the proteinaseresistant form of PrP sc (PrP res ) was carried out on samples of the caudal medulla and medial retropharyngeal lymph node using antibodies Sha31 (aa 156-163) and P4 according to the BioRad TeSeE universal WB protocol (BioRad Laboratories, Hemel Hempstead, UK). Parallel testing with the two specific monoclonal antibodies aids in the discrimination between classical BSE and scrapie where Sha31 detects PrP res in both cattle and sheep, whereas P4 is more selective for scrapie PrP res [22] . Additional antibodies used were 12B2, SAF32 (aa 86-91; SPI-Bio, Bertin Pharma, Montigny le Bretonneux, France) and 9A2. Sigma biotinylated molecular mass markers as well as a known UK classical scrapie (ovine VRQ/VRQ and caprine II 142 ) brain sample, known UK bovine BSE brain sample and known ovine VRQ/VRQ non-neural mesenteric lymph node sample (for WB on lymphoid tissue) were included as positive controls for profile comparisons. All control samples were homogenates from a single naturally infected animal. All samples were tested once. From each sample, 0.35 g tissue was ribolysed, purified, treated with proteinase K (following treatment with DNase for all medial retropharyngeal lymph node samples) and PrP res concentrated according to the kit instructions and with the reagents supplied. As four samples produced weak profiles upon initial examination of caudal medulla tissue, these samples were processed in duplicate and the pellets combined (double pellets) for subsequent runs. Samples were heated for 4 min at 100°C prior to loading on gels. A sample of 15 μl each was loaded in duplicate lanes onto pre-cast 12% bis-tris gels (Criterion, Bio-Rad) and electrophoresed for 50 min at 200 V. The proteins were then transferred onto PVDF membranes (115 V for 60 min) and blocked (Bio-Rad blocking solution for Sha31 and milk powder solution for other antibodies) for 30 min at room temperature. They were probed with the kit primary antibody (Sha31) for 30 min at room temperature and additional antibodies (P4, 12B2, SAF32, 9A2) for 1 h at room temperature.
The membranes were washed, incubated for 20 min in Bio-Rad secondary antibody (Sha31) or goat anti-mouse conjugate (P4, 12B2, SAF32, 9A2) at room temperature, washed again and the membranes were incubated with ECL substrate (Amersham) for 1 min. The signal was detected with the Fluor-S MultiImager (Bio-Rad).
The total amount of PrP res signal emitted from the diglycosylated, monoglycosylated and unglycosylated protein bands was calculated by means of the volume analysis tool in the Quantity One software (Bio-Rad) for antibodies Sha31 and P4. The global background was subtracted and the ratio for the ovine scrapie control sample set at 1; the ratio for the test samples was then calculated relative to the ovine scrapie control sample. The cut off was set at 2.0 and any sample with a ratio below this was considered to be classical scrapie-like and any ratio above this was considered classical BSE-like.
Results
Animal data, such as PRNP genotype, sex and survival time, of the 22 sheep that developed a TSE (ten challenged with brain, 12 challenged with milk) are provided in Table 1 . The influence of PRNP genotype on survival time has already been discussed in the previous publication [9] and will not be mentioned in this manuscript.
Clinical signs
Signs of pruritus, characterised by a stereotypical response to scratching of the back (positive scratch test) and/ or alopecia with or without skin lesions suggestive of excessive rubbing, scratching or nibbling were displayed by all 12 sheep that were either VV or LL 141 (see Additional file 2 for an example of the pruritic form Fig. 2) .
The mean PrP sc profiles of goat brain and milk recipients, separated by PRNP genotype, are shown in Fig. 3 . The profiles were similar in VV and LL 141 sheep but differed from the profiles seen in LF 141 and FF 141 sheep. When the PrP sc profiles from individual sheep were compared within the PRNP genotype group (Fig. 4) , differences were apparent between LL 141 sheep fed milk from different donors but not between LF 141 sheep, which all displayed similar profiles. Also, challenge with brain from the same donor resulted in profile differences in VV sheep but not in FF 141 sheep.
Discriminatory IHC using six different antibodies revealed that antibody detection in the different compartments in CNS tissue of AA sheep was dependent on polymorphisms at codon 141 of the ovine PRNP (see Fig. 5 , which shows the immunolabelling pattern in different compartments using six antibodies with different affinity to ovine PrP sc ). In lymphoid tissue, all antibodies Fig. 1 Electrocardiogram recorded from LL 141 milk recipient 1329 with cardiac arrhythmia. Extract of an electrocardiogram recorded over 5 min prior to cull whilst the animal was restrained in its pen with other sheep; overall heart rate 112 beats per minute. R = R peak intervals; major unit on x axis is second, major unit on y axis is 0.1 mV. Note the irregular rhythm of the R peak intervals, which do not appear to follow a particular pattern detected the same levels of PrP sc in macrophages, which was consistent with classical scrapie.
Individual scores are shown in Additional file 4: clinical and pathological data.
Molecular profiles
Molecular profiles obtained by WB testing of caudal medulla with antibodies Sha31 and P4 are shown in Fig. 6 . Differences were seen in relation to the reactivity with the N-terminal antibody P4, which was dependent on PRNP polymorphisms at codon 141: PrP res was detected with this antibody in VV and LL 141 sheep, similar to the classical scrapie ovine and caprine control samples, whereas reactivity was reduced in LF 141 sheep and greatly reduced or absent in FF 141 sheep, similar to the classical BSE control sample. Similar observations were made with two further N-terminal antibodies, 12B2 and SAF32. The Sha31/P4 antibody ratios were less than 2 for VV and LL 141 sheep as seen with the classical scrapie control samples, but above 2 in LF 141 and FF 141 sheep. In fact, the ratio was above 5 in 4 of 7 LF 141 sheep and in all FF 141 sheep (Fig. 7) . By contrast, WB reactivities to Sha31 and P4 antibodies on medial retropharyngeal lymph node samples were similar for all sheep, regardless of the 141 polymorphism, and similar to the classical scrapie control samples.
Discussion
Although this study was originally carried out to investigate the transmission of scrapie via goat milk using sheep as recipients it has provided valuable information about the influence of the PRNP genotype, particularly at codon 141, on the clinical, pathological and molecular phenotype of goat scrapie in sheep. It has been demonstrated previously that polymorphisms at codon 141 may affect survival time and disease phenotype in sheep on cross-PRNP genotype inoculations with pooled sheep brain homogenate [6] .
Clinically affected sheep presented with a range of clinical signs, which have been reported previously in sheep with scrapie and indicated that caprine scrapie transmitted to sheep produced a clinical disease associated with scrapie in sheep. This included less common signs such as cardiac arrhythmia, cataplexy-like collapse and othaematoma, possibly as a result of excessive pruritus, which have nevertheless been reported in natural scrapie in sheep [18, [23] [24] [25] [26] . Other involuntary movements, such as myoclonus (brief shock-like jerks due to sudden involuntary contraction of one or more muscles [27] ) have been reported in some cases of scrapie [28, 29] but are usually more frequent in BSE in cattle or Creutzfeldt-Jakob disease in humans and often in response to an external stimulus (startle myoclonus) [30] [31] [32] . Clinical disease in sheep may vary according to breed, region and country, presenting either as pruritic or nonpruritic form [33] . The results presented here clearly demonstrate that the clinical phenotype is affected by PRNP genotype, notably polymorphisms at codon 141, of sheep of the same breed. All LL 141 sheep (regardless of donor goat and PRNP genotype at codon 136, VV or AA) exhibited the pruritic form, which is also the predominant form in sheep infected with the BSE agent and characterised by a positive scratch test (lip licking or head movements when the back is scratched), excessive rubbing and scratching resulting in wool loss [19] . By contrast, LF 141 and FF 141 sheep presented with the nervous form, characterised by ataxia and limb weakness without any signs of pruritus, regardless of donor goat, which is clinically unlike experimental BSE in sheep. These results provided further evidence that the clinical presentation is dependent on the PRNP genotype as suggested by studies in naturally infected sheep where strain as confounding factor could not be excluded [29, 34] . The results also provided further evidence that the pathological phenotype was influenced by the PRNP genotype at codon 141. PrP sc profiling by genotype revealed that the profiles did not differ between LF 141 and FF 141 sheep, which was characterised by the predominance of intraneuronal and intraglial PrP sc and an absence of extracellular glia-associated PrP sc , which was in contrast to LL 141 sheep (either VV or AA) where glia-associated PrP sc was more prominent (see Fig. 3 ). These findings were consistent with results from studies in naturally infected sheep or sheep with scrapie induced by experimental cross-genotype transmission, which suggested that PrP sc profiles were influenced by PRNP genotypes although other factors, such as source of infection and survival time could also be contributory [6, 35] . There is evidence from studies in experimentally and naturally infected sheep with scrapie that there is poor association between the severity of clinical signs and the level of PrP res [36] or PrP sc in the brain [37] [38] [39] . This was confirmed in the present study, using an established PrP sc profiling method and detailed and regular clinical examinations for signs of scrapie. If the large variation in the total magnitude of PrP sc immunolabelling in some VV and LL 141 sheep was due to the difference in survival times and the severity of clinical signs despite having been infected with identical volumes of milk or doses of brain from the same donor, sheep with lower total PrP sc scores should have shorter survival times with less severe clinical signs. However, this was not consistently observed. For example, the survival time was not necessarily longer in sheep with a higher PrP sc score (1452 was culled later than 1424 even though the total PrP sc was two times higher in 1424). Studies on the clinical progression in naturally affected sheep with scrapie suggested that head tremor, ataxia, teeth grinding, loss of body condition and loss of a menace response occurred more frequently with disease progression [29, 40] . There was some indication that sheep with higher PrP sc scores, which had been challenged with milk or brain from the same donor, presented with more severe clinical signs: both brain-challenged VV sheep with a lower PrP sc score (1452 and 1425) were not ataxic and had a menace response unlike the other VV sheep (1424), which was ataxic, lost the menace response and had a considerably higher PrP sc score. Similarly, the severity of ataxia was considered less in an LL 141 sheep with low PrP sc score (1294) compared to one with a high PrP sc score (1293), which also lost its appetite. However, two other VV sheep had almost identical signs (both ataxic with head tremor) despite considerable total PrP sc score differences and whilst one (1451) was also teeth grinding, the other (1419) displayed signs of disequilibrium, which suggested more severe gait abnormalities.
The differences in the PrP sc profiles in LL 141 sheep challenged with milk from different donors may be the results of possible strain differences although it does not explain why the same phenomenon was not observed in LF 141 sheep unless the wild-type alleles (LL 141 ) produce greater phenotypic variability.
Similarly, the differences in the PrP sc profiles in VV and LL 141 sheep challenged with brain and milk from the same goat respectively may be to some extent explained by the different survival time and clinical severity of the sheep, which may alter the proportional localisation of PrP sc immunolabelling so that sheep with longer survival times and more severe clinical signs have proportionally more intraneuronal and intraglial and less glia-associated immunolabelling, possibly as a result of progressive removal and internalization of glia-associated PrP sc as the disease progresses (see Fig. 4 : LL 141 sheep 1293 had a longer survival time and more severe clinical signs than 1294). However, this does not quite explain the profile differences seen in VV sheep where the profiles were similar in sheep with the shortest and longest survival time (see Fig. 4 : VV sheep 1418 and 1425 had the shortest survival time and a similar profile to 1451 and 1452 respectively, which had the longest survival time). It also does not explain why LF 141 and FF 141 sheep with comparatively longer survival times than LL 141 sheep accumulate most PrP sc intracellularly and lack gliaassociated PrP sc , which suggests that PrP sc is more prone to be internalized in neurons and not deposited in the membrane of glial cells in sheep carrying the F 141 allele.
Discriminatory IHC using six different antibodies with different affinity to PrP sc sequences is based on the observation that truncation of the prion protein of different strains (classical scrapie, classical ovine BSE and CH1641) is dependent on tissue, cell type and location within the tissue (intra-or extracellular). Extracellular PrP sc , which is not truncated, should be detected similarly with all antibodies whereas intracellular PrP sc is truncated and therefore some antibodies (raised against the globular and C domains) should detect it while others (raised against the N terminus) may not. Whilst discriminatory IHC applied to lymphoid tissue agreed with the molecular profile obtained from lymphoid tissue, which identified the samples as consistent with classical scrapie, tests applied to CNS tissue produced a more varied result, which was dependent on PRNP polymorphisms at codon 141. This particularly affected the detection by N-terminal antibodies, such as 12B2 or P4. The magnitude of PrP sc immunolabelling with the 12B2 antibody was reduced in sheep carrying the F 141 allele compared to LL 141 sheep, which was particularly striking for extracellular and intraglial PrP sc . Similarly, P4 antibody reactivity in the WB was reduced in brains from LF 141 and particularly FF 141 sheep. This antibody is used for the discriminatory WB to distinguish classical scrapie from BSE because brains from classical bovine BSE and experimental classical ovine BSE cases show no and greatly reduced signal, respectively [41] . LL 141 sheep, including VV sheep, were classified as classical scrapie because PrP res was detected with antibody P4, and the Sha31/P4 antibody ratio was as expected for classical scrapie isolates, whereas LF 141 sheep produced an intermediate BSE-like profile with reduced detection with P4, and FF 141 sheep produced a BSE-like profile with little or no PrP res detection with P4 and the Sha31/P4 antibody ratio was unlike classical scrapie for both genotypes.
The results obtained from the discriminatory tests suggested that proteinase K used for WB cleaves brain samples from sheep with the L 141 allotype towards the N terminus from the P4 epitope, thus resulting in PrP res detection by both Sha31 and P4. In contrast, proteinase K appeared to cleave the F 141 PrP protein towards the C terminus from the P4 epitope, possibly around the 141 position, thus resulting in detection by Sha31 (aa residue binding sites 148-155, see Figure 5 ) but not by P4 (aa 93-99 The WB results highlight the difficulty in interpreting the discriminatory WB by examination of brain in cross-species transmission experiments because LF 141 and particularly FF 141 sheep demonstrated a classical BSE-like profile, even though there was sufficient evidence that the isolate was not BSE: i) LL 141 sheep challenged with the same isolate produced a profile consistent with classical scrapie; ii) testing of lymphoid tissue produced a molecular and pathological phenotype consistent with classical scrapie; iii) the discriminatory IHC was unlike BSE and iv) the lack of pruritus in LF 141 and FF 141 was inconsistent with the clinical phenotype reported for classical BSE in sheep [19] . There is currently no evidence that this poses a problem for potential misdiagnosis during discriminatory testing of positive small ruminant field cases in accordance with current European Union legislation if similar cross-species transmission occurred naturally but the process of referral for a case giving an initial BSE-like characteristic initiates further investigative testing that would rule out BSE.
Conclusions
In summary, this study provided evidence that the clinical, pathological and molecular phenotype of classical scrapie transmitted from goats to sheep is affected by PRNP polymorphisms, particularly at codon 141, which has to be taken into account when investigating strain characteristics by laboratory methods. 
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